|
|
Blood, 1 July 2005, Vol. 106, No. 1, pp. 372-375.
Prepublished online as a Blood First Edition Paper on March 22, 2005; DOI 10.1182/blood-2005-02-0548.
Previous Article | Next Article 
Submitted February 8, 2005
Accepted March 10, 2005
Association of Klotho, bone morphogenic protein 6 and annexin A2 polymorphisms with sickle cell osteonecrosis
Clinton Baldwin*, Vikky G Nolan, Diego F Wyszynski, Qian-Li Ma, Paola Sebastiani, Stephen H Embury, Alice Bisbee, John Farrell, Lindsay Farrer, and Martin H Steinberg
Center for Human Genetics, Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA; Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Department of Medicine, Boston University School of Medicine, Boston, MA, USA
Department of Medicine, Boston University School of Medicine, Boston, MA, USA; Boston University School of Public Health, Boston, MA, USA
Boston University School of Public Health, Boston, MA, USA
Department of Medicine, University of California at San Francisco and San Francisco General Hospital, San Franciso, CA, USA
* Corresponding author; email: cbaldwin{at}bu.edu.
In patients with sickle cell disease, clinical complications including osteonecrosis can vary in frequency and severity, presumably due to the effects of genes that modify the pathophysiology initiated by the sickle mutation. Here, we examined the association of single-nucleotide polymorphisms in candidate genes (cytokines, inflammation, oxidant stress, bone metabolism) with osteonecrosis in patients with sickle cell disease. Genotype distributions were compared between cases and controls using multiple logistic regression techniques. An initial screen and follow-up studies showed that individual SNPs and haplotypes comprised of several SNPs in bone morphogenetic protein 6, annexin 2, and klotho were associated with sickle cell osteonecrosis. These genes are important in bone morphology, metabolism and vascular disease. Our results may provide insight into the pathogenesis of osteonecrosis in sickle cell disease, help identify individuals who are at high risk for osteonecrosis, and thus allow earlier and more effective therapeutic intervention.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Mont, L. C. Jones, and D. S. Hungerford
Nontraumatic Osteonecrosis of the Femoral Head: Ten Years Later
J. Bone Joint Surg. Am.,
May 1, 2006;
88(5):
1117 - 1132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sebastiani, C. T. Baldwin, V. Nolan, D. F. Wyszynski, Q.-L. Ma, J. Farrell, A. Bisbee, K. Waraska, L. A. Farrer, and M. H. Steinberg
Polymorphisms (Snps) in Multiple Genes of the Tgf-{beta}/Bmp Pathway Are Associated with a Global Measure of Sickle Cell Disease Severity.
Blood (ASH Annual Meeting Abstracts),
November 16, 2005;
106(11):
74 - 74.
[Abstract]
|
 |
|

|
 |

|
 |
 
V. G. Nolan, A. C. Rybicki, C. T. Baldwin, H. T. Cohen, A. H. Adewoye, D. F. Wyszynski, M. E. Fabry, R. L. Nagel, and M. H. Steinberg
Creatinine Clearance in Sickle Cell Anemia Is Modulated by Genes in the TGF-{beta}/BMP Pathway.
Blood (ASH Annual Meeting Abstracts),
November 16, 2005;
106(11):
3175 - 3175.
[Abstract]
|
 |
|
|
|